Data Bridge Market Research Adds “
Global Women’s Health Diagnostics Market – Industry Trends and Forecast to 2028” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of Tables: 220 in it. This comprehensive
Global Women’s Health Diagnostics Market industry research report includes a brief on these trends that can help the organizations operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market CAGR,Volume, industry share And size, demand and trend growth, key segments, and key drivers and restrains.
New Players in the market are facing tough competition from established international Players as they struggle with technological innovations, reliability and quality issues. The report will answer questions about the current market developments and the scope of competition, opportunity cost and more.
Progenity Reaches Two Million Test Milestone
The company celebrates its ten-year anniversary and looks toward future innovations
SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, has reported the completion of two million diagnostic tests by its CLIA-certified and CAP-accredited laboratory in Ann Arbor, Michigan. This notable milestone comes as Progenity celebrates the ten-year anniversary of the company’s founding.
Progenity was established in 2011 as a women’s health molecular diagnostics company offering a genetic carrier test for the detection of cystic fibrosis. Today, the company has commercialized a portfolio of diagnostic products, including the Preparent